Dayle Sampson, PhD

Vice President, Bioinformatics, Elysium Health · Elysium Health

Elysium VP of Bioinformatics leading APEX algorithm work behind the Index biological-age test

English
Dayle Sampson, PhD portrait

About

Dayle Sampson, PhD is Elysium Health's Vice President of Bioinformatics and a lead developer of APEX, the algorithmic platform behind the Index biological-age test. His background is applied machine learning, computational biology, and biomarker discovery. Before Elysium, he was Director of Bioinformatics at Immunexpress, where his work on host-immune-response sepsis diagnostics contributed to two FDA 510(k) de novo clearances. He holds a PhD in bioinformatics and a BAppSci (Hons) in biotechnology and forensic science from Queensland University of Technology.

What to Know

Signature approach

Sampson's Elysium work is the computational layer of Index: turning methylation data from the custom chip into biological age, pace of aging, and system-age outputs. The pattern matches his Immunexpress background: train on a defined biological signal, validate the model, and move the result into a product workflow.

What sets them apart

  • APEX role. He is tied directly to the algorithm behind Index reports.
  • Regulatory diagnostics background. Immunexpress work connects him to two FDA 510(k) de novo clearances before Elysium.
  • Applied-ML specialization. His public profile centers on biomarker discovery, multiomics, and health AI/ML.
  • Publication base. ResearchGate listed 24 works and 269 citations across sepsis transcriptomics, wound-healing proteomics, and exercise physiology at capture.

Affiliations

Head of Research

Thought Leadership

Other specialists at Elysium Health

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.